₹ 2.0 Cr
Volume Transacted
(Jan 15, 2025)
16.6 K
Stocks Traded
(Jan 15, 2025)
Last Updated on: Jan 15, 2025
Natco Pharma Ltd
NSE: NATCOPHARM
ISIN
INE987B01026
Last updated on: Jan 15, 2025
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Natco Pharma Ltd
NSE: NATCOPHARM
Share Price
₹ 1220.6
-35.20 (-2.80%)
Last updated on: Jan 15, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
15 Jan 2025 | 1220.6 | 1266 | 1266 | 1216.65 |
14 Jan 2025 | 1255.8 | 1222.9 | 1264.65 | 1222.9 |
13 Jan 2025 | 1212.35 | 1210 | 1249.5 | 1201 |
10 Jan 2025 | 1235.5 | 1289 | 1293.85 | 1230.1 |
09 Jan 2025 | 1288.95 | 1318.25 | 1319 | 1286.75 |
08 Jan 2025 | 1318.7 | 1334.8 | 1334.8 | 1310.65 |
07 Jan 2025 | 1326.6 | 1311.45 | 1337.4 | 1311.45 |
06 Jan 2025 | 1310.15 | 1342.05 | 1365 | 1305.15 |
03 Jan 2025 | 1366.85 | 1393.7 | 1393.7 | 1365 |
02 Jan 2025 | 1385.35 | 1400.05 | 1419.5 | 1378.75 |
Date | Price (₹) |
---|---|
15 Jan 2025 | 1220.6 |
14 Jan 2025 | 1255.8 |
13 Jan 2025 | 1212.35 |
10 Jan 2025 | 1235.5 |
09 Jan 2025 | 1288.95 |
08 Jan 2025 | 1318.7 |
07 Jan 2025 | 1326.6 |
06 Jan 2025 | 1310.15 |
03 Jan 2025 | 1366.85 |
02 Jan 2025 | 1385.35 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Last updated time: 15 Jan 15:30 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Natco Pharma Ltd gains for third straight session
Natco Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1479...
19 Dec 2024 13:05
Natco Pharma Ltd soars 1.05%, Gains for third straight session
Natco Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1...
03 Dec 2024 13:06
Natco Pharma sells Telangana land for Rs 116 crore
The drug maker stated that since no business operations are carried out on the said land a...
28 Nov 2024 11:31
Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution
Natco Pharma today announced submission of Abbreviated New Drug Application (ANDA) with US...
21 Nov 2024 17:35
Natco Pharma submits ANDA with US FDA for Risdiplam
The ANDA is a generic version of Evrysdi (Risdiplam) for oral solution by Genentech Inc. R...
21 Nov 2024 15:00
Natco Pharma Ltd eases for fifth straight session
Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 13...
13 Nov 2024 13:14
Unlimited trading starting at just Rs. 249*